Consun Pharmaceutical Group Limited (FRA:C1P)

FRA:C1P Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,638	842	438	383	394	257
Market Cap Growth	110.00%	92.35%	14.25%	-2.77%	53.22%	-42.71%
Enterprise Value	1,226	471	146	147	240	184
Last Close Price	1.86	0.98	0.44	0.36	0.34	0.21
PE Ratio	13.66	6.99	4.37	4.14	4.82	4.12
PS Ratio	4.22	2.14	1.33	1.21	1.39	1.17
PB Ratio	2.97	1.45	0.88	0.82	0.98	0.82
P/TBV Ratio	3.37	1.66	1.03	1.00	1.25	1.11
P/FCF Ratio	12.05	6.51	4.48	3.15	4.54	2.51
P/OCF Ratio	11.21	5.85	4.19	2.98	3.92	2.37
EV/Sales Ratio	3.18	1.20	0.44	0.46	0.85	0.84
EV/EBITDA Ratio	9.19	3.45	1.27	1.38	2.38	2.37
EV/EBIT Ratio	9.68	3.65	1.38	1.51	2.63	2.67
EV/FCF Ratio	9.02	3.64	1.49	1.21	2.77	1.79
Debt / Equity Ratio	0.06	0.06	0.13	0.13	0.21	0.22
Debt / EBITDA Ratio	0.22	0.26	0.57	0.58	0.83	0.88
Debt / FCF Ratio	0.22	0.27	0.67	0.51	0.97	0.67
Asset Turnover	0.56	0.52	0.50	0.51	0.49	0.46
Inventory Turnover	2.35	2.07	1.99	2.12	2.13	1.97
Quick Ratio	3.29	3.09	2.60	2.47	2.06	1.80
Current Ratio	3.54	3.32	2.86	2.68	2.25	2.00
Return on Equity (ROE)	23.60%	22.07%	21.38%	21.53%	21.64%	19.98%
Return on Assets (ROA)	11.58%	10.73%	9.93%	9.66%	9.93%	8.98%
Return on Invested Capital (ROIC)	113.06%	106.82%	88.13%	67.03%	50.16%	34.89%
Return on Capital Employed (ROCE)	22.60%	21.80%	20.60%	20.20%	22.00%	21.00%
Earnings Yield	7.32%	14.31%	22.87%	24.18%	20.73%	24.28%
FCF Yield	8.30%	15.37%	22.34%	31.73%	22.03%	39.84%
Dividend Yield	3.75%	7.60%	11.75%	10.07%	9.85%	14.27%
Payout Ratio	45.94%	74.75%	41.59%	18.67%	33.56%	26.36%
Buyback Yield / Dilution	-6.04%	-4.12%	-0.91%	1.58%	1.54%	4.35%
Total Shareholder Return	-2.29%	3.48%	10.85%	11.65%	11.39%	18.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.